For research and educational reference only does not constitute medical advice
Preclinical colitis models: KPV reduces mucosal inflammation in preclinical colitis models, with demonstrated reductions in TNF-, IL-6, and other pro-inflammatory markers
and is both neuroprotective and cardioprotective (Seeds, 2020)
Pain during gripping activities, weakness in the affected arm, and decreased function can persist for months or even years
For individuals with arthritis, this means potentially faster recovery from joint injuries or damage, contributing to better long-term joint health
Health Canada has issued multiple public advisories since 2023 on unauthorized injectable peptide products, with BPC-157 named explicitly on the list of seized substances in actions against Canlab Research, Prime Research, and other vendors